ANATOMIC STAGE IV BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IV BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IV BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Bone-Seeking' radiation drug enters human trials for advanced cancers
Disease control Not yet recruitingThis is a first-in-human study to find a safe dose of a new radioactive drug, Sn-117m-DTPA, for patients whose prostate, breast, or non-small cell lung cancer has spread to their bones. The drug is designed to deliver radiation directly to bone tumors while trying to spare the he…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New attack on tough breast cancer: radiation supercharges immune therapy
Disease control Not yet recruitingThis study is testing whether adding a short, high-dose course of radiation to standard immunotherapy and chemotherapy can better control an aggressive type of breast cancer that has spread. It will involve about 29 patients whose cancer has a specific marker (PD-L1 positive). Th…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radioactive 'Tumor Hunter' drug tested in advanced breast cancer patients
Disease control Not yet recruitingThis study is testing a new, targeted radioactive drug called 177Lu-DOTATATE in patients with advanced breast cancer that has spread or returned. The drug is designed to seek out and attach to specific cancer cells, delivering radiation directly to the tumor to try to shrink it a…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Blood pressure pill may reboot cancer treatment for Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is for people with advanced triple-negative breast cancer that has stopped responding to a standard immunotherapy drug (pembrolizumab). Researchers want to see if adding a common, low-cost blood pressure drug called propranolol can 're-sensitize' the cancer, making the…
Matched conditions: ANATOMIC STAGE IV BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC